The Market Reports

Index

1 Meningococcal Vaccination Market Overview
1.1 Meningococcal Vaccination Product Scope
1.2 Meningococcal Vaccination Segment by Type
1.2.1 Global Meningococcal Vaccination Sales by Type (2016 & 2021 & 2027)
1.2.2 Polysaccharide
1.2.3 Conjugate
1.2.4 Combination
1.3 Meningococcal Vaccination Segment by Application
1.3.1 Global Meningococcal Vaccination Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others
1.4 Meningococcal Vaccination Market Estimates and Forecasts (2016-2027)
1.4.1 Global Meningococcal Vaccination Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Meningococcal Vaccination Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Meningococcal Vaccination Price Trends (2016-2027)

2 Meningococcal Vaccination Estimates and Forecasts by Region
2.1 Global Meningococcal Vaccination Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Meningococcal Vaccination Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Meningococcal Vaccination Sales Market Share by Region (2016-2021)
2.2.2 Global Meningococcal Vaccination Revenue Market Share by Region (2016-2021)
2.3 Global Meningococcal Vaccination Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Meningococcal Vaccination Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Meningococcal Vaccination Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Meningococcal Vaccination Estimates and Projections (2016-2027)
2.4.2 Europe Meningococcal Vaccination Estimates and Projections (2016-2027)
2.4.3 China Meningococcal Vaccination Estimates and Projections (2016-2027)
2.4.4 Japan Meningococcal Vaccination Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Meningococcal Vaccination Estimates and Projections (2016-2027)
2.4.6 India Meningococcal Vaccination Estimates and Projections (2016-2027)
3 Global Meningococcal Vaccination Competition Landscape by Players
3.1 Global Top Meningococcal Vaccination Players by Sales (2016-2021)
3.2 Global Top Meningococcal Vaccination Players by Revenue (2016-2021)
3.3 Global Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Vaccination as of 2020)
3.4 Global Meningococcal Vaccination Average Price by Company (2016-2021)
3.5 Manufacturers Meningococcal Vaccination Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Meningococcal Vaccination Market Size by Type
4.1 Global Meningococcal Vaccination Historic Market Review by Type (2016-2021)
4.1.1 Global Meningococcal Vaccination Sales Market Share by Type (2016-2021)
4.1.2 Global Meningococcal Vaccination Revenue Market Share by Type (2016-2021)
4.1.3 Global Meningococcal Vaccination Price by Type (2016-2021)
4.2 Global Meningococcal Vaccination Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Meningococcal Vaccination Sales Forecast by Type (2022-2027)
4.2.2 Global Meningococcal Vaccination Revenue Forecast by Type (2022-2027)
4.2.3 Global Meningococcal Vaccination Price Forecast by Type (2022-2027)
5 Global Meningococcal Vaccination Market Size by Application
5.1 Global Meningococcal Vaccination Historic Market Review by Application (2016-2021)
5.1.1 Global Meningococcal Vaccination Sales Market Share by Application (2016-2021)
5.1.2 Global Meningococcal Vaccination Revenue Market Share by Application (2016-2021)
5.1.3 Global Meningococcal Vaccination Price by Application (2016-2021)
5.2 Global Meningococcal Vaccination Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Meningococcal Vaccination Sales Forecast by Application (2022-2027)
5.2.2 Global Meningococcal Vaccination Revenue Forecast by Application (2022-2027)
5.2.3 Global Meningococcal Vaccination Price Forecast by Application (2022-2027)

6 North America Meningococcal Vaccination Market Facts & Figures
6.1 North America Meningococcal Vaccination Sales by Company
6.1.1 North America Meningococcal Vaccination Sales by Company (2016-2021)
6.1.2 North America Meningococcal Vaccination Revenue by Company (2016-2021)
6.2 North America Meningococcal Vaccination Sales Breakdown by Type
6.2.1 North America Meningococcal Vaccination Sales Breakdown by Type (2016-2021)
6.2.2 North America Meningococcal Vaccination Sales Breakdown by Type (2022-2027)
6.3 North America Meningococcal Vaccination Sales Breakdown by Application
6.3.1 North America Meningococcal Vaccination Sales Breakdown by Application (2016-2021)
6.3.2 North America Meningococcal Vaccination Sales Breakdown by Application (2022-2027)

7 Europe Meningococcal Vaccination Market Facts & Figures
7.1 Europe Meningococcal Vaccination Sales by Company
7.1.1 Europe Meningococcal Vaccination Sales by Company (2016-2021)
7.1.2 Europe Meningococcal Vaccination Revenue by Company (2016-2021)
7.2 Europe Meningococcal Vaccination Sales Breakdown by Type
7.2.1 Europe Meningococcal Vaccination Sales Breakdown by Type (2016-2021)
7.2.2 Europe Meningococcal Vaccination Sales Breakdown by Type (2022-2027)
7.3 Europe Meningococcal Vaccination Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Meningococcal Vaccination Market Facts & Figures
8.1 China Meningococcal Vaccination Sales by Company
8.1.1 China Meningococcal Vaccination Sales by Company (2016-2021)
8.1.2 China Meningococcal Vaccination Revenue by Company (2016-2021)
8.2 China Meningococcal Vaccination Sales Breakdown by Type
8.2.1 China Meningococcal Vaccination Sales Breakdown by Type (2016-2021)
8.2.2 China Meningococcal Vaccination Sales Breakdown by Type (2022-2027)
8.3 China Meningococcal Vaccination Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Meningococcal Vaccination Market Facts & Figures
9.1 Japan Meningococcal Vaccination Sales by Company
9.1.1 Japan Meningococcal Vaccination Sales by Company (2016-2021)
9.1.2 Japan Meningococcal Vaccination Revenue by Company (2016-2021)
9.2 Japan Meningococcal Vaccination Sales Breakdown by Type
9.2.1 Japan Meningococcal Vaccination Sales Breakdown by Type (2016-2021)
9.2.2 Japan Meningococcal Vaccination Sales Breakdown by Type (2022-2027)
9.3 Japan Meningococcal Vaccination Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Meningococcal Vaccination Market Facts & Figures
10.1 Southeast Asia Meningococcal Vaccination Sales by Company
10.1.1 Southeast Asia Meningococcal Vaccination Sales by Company (2016-2021)
10.1.2 Southeast Asia Meningococcal Vaccination Revenue by Company (2016-2021)
10.2 Southeast Asia Meningococcal Vaccination Sales Breakdown by Type
10.2.1 Southeast Asia Meningococcal Vaccination Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Meningococcal Vaccination Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Meningococcal Vaccination Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Meningococcal Vaccination Market Facts & Figures
11.1 India Meningococcal Vaccination Sales by Company
11.1.1 India Meningococcal Vaccination Sales by Company (2016-2021)
11.1.2 India Meningococcal Vaccination Revenue by Company (2016-2021)
11.2 India Meningococcal Vaccination Sales Breakdown by Type
11.2.1 India Meningococcal Vaccination Sales Breakdown by Type (2016-2021)
11.2.2 India Meningococcal Vaccination Sales Breakdown by Type (2022-2027)
11.3 India Meningococcal Vaccination Sales Breakdown by Application
11.3.1 India Meningococcal Vaccination Sales Breakdown by Application (2016-2021)
11.3.2 India Meningococcal Vaccination Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Meningococcal Vaccination Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Business Overview
12.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline Meningococcal Vaccination Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 JN-International Medical
12.2.1 JN-International Medical Corporation Information
12.2.2 JN-International Medical Business Overview
12.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.2.4 JN-International Medical Meningococcal Vaccination Products Offered
12.2.5 JN-International Medical Recent Development
12.3 Novartis International
12.3.1 Novartis International Corporation Information
12.3.2 Novartis International Business Overview
12.3.3 Novartis International Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis International Meningococcal Vaccination Products Offered
12.3.5 Novartis International Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Meningococcal Vaccination Products Offered
12.4.5 Sanofi Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Meningococcal Vaccination Products Offered
12.5.5 Pfizer Recent Development
12.6 Baxter International
12.6.1 Baxter International Corporation Information
12.6.2 Baxter International Business Overview
12.6.3 Baxter International Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Baxter International Meningococcal Vaccination Products Offered
12.6.5 Baxter International Recent Development
12.7 Biomed
12.7.1 Biomed Corporation Information
12.7.2 Biomed Business Overview
12.7.3 Biomed Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Biomed Meningococcal Vaccination Products Offered
12.7.5 Biomed Recent Development
12.8 Serum Institute of India
12.8.1 Serum Institute of India Corporation Information
12.8.2 Serum Institute of India Business Overview
12.8.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Serum Institute of India Meningococcal Vaccination Products Offered
12.8.5 Serum Institute of India Recent Development

13 Meningococcal Vaccination Manufacturing Cost Analysis
13.1 Meningococcal Vaccination Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Meningococcal Vaccination
13.4 Meningococcal Vaccination Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Meningococcal Vaccination Distributors List
14.3 Meningococcal Vaccination Customers

15 Market Dynamics
15.1 Meningococcal Vaccination Market Trends
15.2 Meningococcal Vaccination Drivers
15.3 Meningococcal Vaccination Market Challenges
15.4 Meningococcal Vaccination Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Meningococcal Vaccination Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Meningococcal Vaccination Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Meningococcal Vaccination Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Meningococcal Vaccination Sales (K Units) by Region (2016-2021)
Table 5. Global Meningococcal Vaccination Sales Market Share by Region (2016-2021)
Table 6. Global Meningococcal Vaccination Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Meningococcal Vaccination Revenue Share by Region (2016-2021)
Table 8. Global Meningococcal Vaccination Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Meningococcal Vaccination Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Meningococcal Vaccination Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Meningococcal Vaccination Revenue Share Forecast by Region (2022-2027)
Table 12. Global Meningococcal Vaccination Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Meningococcal Vaccination Sales Share by Company (2016-2021)
Table 14. Global Meningococcal Vaccination Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Meningococcal Vaccination Revenue Share by Company (2016-2021)
Table 16. Global Meningococcal Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccination as of 2020)
Table 17. Global Meningococcal Vaccination Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Meningococcal Vaccination Manufacturing Sites and Area Served
Table 19. Manufacturers Meningococcal Vaccination Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Meningococcal Vaccination Sales (K Units) by Type (2016-2021)
Table 22. Global Meningococcal Vaccination Sales Share by Type (2016-2021)
Table 23. Global Meningococcal Vaccination Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Meningococcal Vaccination Price (US$/Unit) by Type (2016-2021)
Table 25. Global Meningococcal Vaccination Sales Share by Type (2022-2027)
Table 26. Global Meningococcal Vaccination Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Meningococcal Vaccination Revenue Share by Type (2022-2027)
Table 28. Global Meningococcal Vaccination Price (US$/Unit) by Type (2022-2027)
Table 29. Global Meningococcal Vaccination Sales (K Units) by Application (2016-2021)
Table 30. Global Meningococcal Vaccination Sales Share by Application (2016-2021)
Table 31. Global Meningococcal Vaccination Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Meningococcal Vaccination Price (US$/Unit) by Application (2016-2021)
Table 33. Global Meningococcal Vaccination Sales (K Units) by Application (2022-2027)
Table 34. Global Meningococcal Vaccination Sales Share by Application (2022-2027)
Table 35. Global Meningococcal Vaccination Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Meningococcal Vaccination Revenue Share by Application (2022-2027)
Table 37. Global Meningococcal Vaccination Price (US$/Unit) by Application (2022-2027)
Table 38. North America Meningococcal Vaccination Sales (K Units) by Company (2016-2021)
Table 39. North America Meningococcal Vaccination Sales Market Share by Company (2016-2021)
Table 40. North America Meningococcal Vaccination Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Meningococcal Vaccination Revenue Market Share by Company (2016-2021)
Table 42. North America Meningococcal Vaccination Sales by Type (2016-2021) & (K Units)
Table 43. North America Meningococcal Vaccination Sales Market Share by Type (2016-2021)
Table 44. North America Meningococcal Vaccination Sales by Type (2022-2027) & (K Units)
Table 45. North America Meningococcal Vaccination Sales Market Share by Type (2022-2027)
Table 46. North America Meningococcal Vaccination Sales by Application (2016-2021) & (K Units)
Table 47. North America Meningococcal Vaccination Sales Market Share by Application (2016-2021)
Table 48. North America Meningococcal Vaccination Sales by Application (2022-2027) & (K Units)
Table 49. North America Meningococcal Vaccination Sales Market Share by Application (2022-2027)
Table 50. Europe Meningococcal Vaccination Sales (K Units) by Company (2016-2021)
Table 51. Europe Meningococcal Vaccination Sales Market Share by Company (2016-2021)
Table 52. Europe Meningococcal Vaccination Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Meningococcal Vaccination Revenue Market Share by Company (2016-2021)
Table 54. Europe Meningococcal Vaccination Sales by Type (2016-2021) & (K Units)
Table 55. Europe Meningococcal Vaccination Sales Market Share by Type (2016-2021)
Table 56. Europe Meningococcal Vaccination Sales by Type (2022-2027) & (K Units)
Table 57. Europe Meningococcal Vaccination Sales Market Share by Type (2022-2027)
Table 58. Europe Meningococcal Vaccination Sales by Application (2016-2021) & (K Units)
Table 59. Europe Meningococcal Vaccination Sales Market Share by Application (2016-2021)
Table 60. Europe Meningococcal Vaccination Sales by Application (2022-2027) & (K Units)
Table 61. Europe Meningococcal Vaccination Sales Market Share by Application (2022-2027)
Table 62. China Meningococcal Vaccination Sales (K Units) by Company (2016-2021)
Table 63. China Meningococcal Vaccination Sales Market Share by Company (2016-2021)
Table 64. China Meningococcal Vaccination Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Meningococcal Vaccination Revenue Market Share by Company (2016-2021)
Table 66. China Meningococcal Vaccination Sales by Type (2016-2021) & (K Units)
Table 67. China Meningococcal Vaccination Sales Market Share by Type (2016-2021)
Table 68. China Meningococcal Vaccination Sales by Type (2022-2027) & (K Units)
Table 69. China Meningococcal Vaccination Sales Market Share by Type (2022-2027)
Table 70. China Meningococcal Vaccination Sales by Application (2016-2021) & (K Units)
Table 71. China Meningococcal Vaccination Sales Market Share by Application (2016-2021)
Table 72. China Meningococcal Vaccination Sales by Application (2022-2027) & (K Units)
Table 73. China Meningococcal Vaccination Sales Market Share by Application (2022-2027)
Table 74. Japan Meningococcal Vaccination Sales (K Units) by Company (2016-2021)
Table 75. Japan Meningococcal Vaccination Sales Market Share by Company (2016-2021)
Table 76. Japan Meningococcal Vaccination Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Meningococcal Vaccination Revenue Market Share by Company (2016-2021)
Table 78. Japan Meningococcal Vaccination Sales by Type (2016-2021) & (K Units)
Table 79. Japan Meningococcal Vaccination Sales Market Share by Type (2016-2021)
Table 80. Japan Meningococcal Vaccination Sales by Type (2022-2027) & (K Units)
Table 81. Japan Meningococcal Vaccination Sales Market Share by Type (2022-2027)
Table 82. Japan Meningococcal Vaccination Sales by Application (2016-2021) & (K Units)
Table 83. Japan Meningococcal Vaccination Sales Market Share by Application (2016-2021)
Table 84. Japan Meningococcal Vaccination Sales by Application (2022-2027) & (K Units)
Table 85. Japan Meningococcal Vaccination Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Meningococcal Vaccination Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Meningococcal Vaccination Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Meningococcal Vaccination Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Meningococcal Vaccination Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Meningococcal Vaccination Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Meningococcal Vaccination Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Meningococcal Vaccination Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Meningococcal Vaccination Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Meningococcal Vaccination Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Meningococcal Vaccination Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Meningococcal Vaccination Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Meningococcal Vaccination Sales Market Share by Application (2022-2027)
Table 98. India Meningococcal Vaccination Sales (K Units) by Company (2016-2021)
Table 99. India Meningococcal Vaccination Sales Market Share by Company (2016-2021)
Table 100. India Meningococcal Vaccination Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Meningococcal Vaccination Revenue Market Share by Company (2016-2021)
Table 102. India Meningococcal Vaccination Sales by Type (2016-2021) & (K Units)
Table 103. India Meningococcal Vaccination Sales Market Share by Type (2016-2021)
Table 104. India Meningococcal Vaccination Sales by Type (2022-2027) & (K Units)
Table 105. India Meningococcal Vaccination Sales Market Share by Type (2022-2027)
Table 106. India Meningococcal Vaccination Sales by Application (2016-2021) & (K Units)
Table 107. India Meningococcal Vaccination Sales Market Share by Application (2016-2021)
Table 108. India Meningococcal Vaccination Sales by Application (2022-2027) & (K Units)
Table 109. India Meningococcal Vaccination Sales Market Share by Application (2022-2027)
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. GlaxoSmithKline Meningococcal Vaccination Product
Table 114. GlaxoSmithKline Recent Development
Table 115. JN-International Medical Corporation Information
Table 116. JN-International Medical Description and Business Overview
Table 117. JN-International Medical Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. JN-International Medical Meningococcal Vaccination Product
Table 119. JN-International Medical Recent Development
Table 120. Novartis International Corporation Information
Table 121. Novartis International Description and Business Overview
Table 122. Novartis International Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Novartis International Meningococcal Vaccination Product
Table 124. Novartis International Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Sanofi Meningococcal Vaccination Product
Table 129. Sanofi Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Pfizer Meningococcal Vaccination Product
Table 134. Pfizer Recent Development
Table 135. Baxter International Corporation Information
Table 136. Baxter International Description and Business Overview
Table 137. Baxter International Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Baxter International Meningococcal Vaccination Product
Table 139. Baxter International Recent Development
Table 140. Biomed Corporation Information
Table 141. Biomed Description and Business Overview
Table 142. Biomed Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Biomed Meningococcal Vaccination Product
Table 144. Biomed Recent Development
Table 145. Serum Institute of India Corporation Information
Table 146. Serum Institute of India Meningococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Serum Institute of India Description and Business Overview
Table 148. Serum Institute of India Meningococcal Vaccination Product
Table 149. Serum Institute of India Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Meningococcal Vaccination Distributors List
Table 153. Meningococcal Vaccination Customers List
Table 154. Meningococcal Vaccination Market Trends
Table 155. Meningococcal Vaccination Market Drivers
Table 156. Meningococcal Vaccination Market Challenges
Table 157. Meningococcal Vaccination Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Vaccination Product Picture
Figure 2. Global Meningococcal Vaccination Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Meningococcal Vaccination Sales Market Share by Application in 2021 & 2027
Figure 6. Pneumonia Examples
Figure 7. Meningitis Examples
Figure 8. Bacteremia Examples
Figure 9. Others Examples
Figure 10. Global Meningococcal Vaccination Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Meningococcal Vaccination Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Meningococcal Vaccination Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Meningococcal Vaccination Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Meningococcal Vaccination Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Meningococcal Vaccination Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Meningococcal Vaccination Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Meningococcal Vaccination Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Meningococcal Vaccination Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Meningococcal Vaccination Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Meningococcal Vaccination Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Meningococcal Vaccination Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Meningococcal Vaccination Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Meningococcal Vaccination Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Meningococcal Vaccination Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Meningococcal Vaccination Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Meningococcal Vaccination Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Meningococcal Vaccination Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Meningococcal Vaccination Players Market Share by Revenue in Meningococcal Vaccination: 2016 & 2020
Figure 29. Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Meningococcal Vaccination Revenue Share by Type (2016-2021)
Figure 31. Global Meningococcal Vaccination Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Meningococcal Vaccination Revenue Share by Application (2016-2021)
Figure 33. Global Meningococcal Vaccination Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Meningococcal Vaccination Sales Market Share by Type in 2020
Figure 35. North America Meningococcal Vaccination Sales Market Share by Application in 2020
Figure 36. Europe Meningococcal Vaccination Sales Market Share by Type in 2020
Figure 37. Europe Meningococcal Vaccination Sales Market Share by Application in 2020
Figure 38. China Meningococcal Vaccination Sales Market Share by Type in 2020
Figure 39. China Meningococcal Vaccination Sales Market Share by Application in 2020
Figure 40. Japan Meningococcal Vaccination Sales Market Share by Type in 2020
Figure 41. Japan Meningococcal Vaccination Sales Market Share by Application in 2020
Figure 42. Southeast Asia Meningococcal Vaccination Sales Market Share by Type in 2020
Figure 43. Southeast Asia Meningococcal Vaccination Sales Market Share by Application in 2020
Figure 44. India Meningococcal Vaccination Sales Market Share by Type in 2020
Figure 45. India Meningococcal Vaccination Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Meningococcal Vaccination
Figure 48. Manufacturing Process Analysis of Meningococcal Vaccination
Figure 49. Meningococcal Vaccination Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed